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Summary and Implications
We predict that it may be possible to improve pig disease
resistance to Salmonella infection by studying genes that
control a piglet’s initial immune response. The NRAMP1
gene controls susceptibility to multiple pathogens and acts
within the macrophage. The BPI gene encodes a
neutrophil protein with inhibitory/killing functions against
multiple gram-negative bacteria. We investigated
NRAMP1 and BPI as candidate genes for contributing to
resistance in Salmonella choleraesuis (SC) challenge in
pigs. Five NRAMP1 sequence differences
(polymorphisms, SNPs) were found, while we cloned and
sequenced the full-length BPI gene and identified four
polymorphisms at BPI. The effects these polymorphisms
have on resistance to infection were tested in two
experimental disease studies. In study 1, results showed
NRAMP1 and BPI genotypes were associated with
decreased fecal bacterial load during infection (P values:
< .0006 to < .06). Immune cell numbers were also
associated with BPI genotypes. In the second study, many
additional immune traits and spleen and liver bacterial
counts were collected. The NRAMP1 genotypes were
associated with bacterial count in liver (P < .05 and P <
.0006) and with polymorphonuclear phagocytes (P values
from < .003 to < .05). The BPI genotypes were
significantly associated with bacteria uptake by immune
cells and with bacterial counts in liver (P<.1) and
lymphocyte response post-challenge (P<.0001). These
data indicate NRAMP1 and/or BPI gene variation may
control, in part, response to Salmonella infection in pigs,
and that these differences could be used to identify
resistant animals.
Introduction
The NRAMP1 protein plays a pivotal role in the
course of early infection by Mycobacteria, Leishmania,
and Salmonella. Mice with a mutation at NRAMP1 proved
that NRAMP1 mutations cause susceptibility to these
different pathogens. NRAMP1 protein is localized to the
lysophagosomal membrane of differentiated phagocytes,
indicating a role in innate (pre-adaptive) immunity.
Manipulation of the NRAMP1 gene in livestock and
possibly in humans has the potential to greatly improve
health and reduce dependence on antibiotics. However,
manipulation at the NRAMP1 locus must be approached
with caution, as improved infectious disease immunity by
NRAMP1 gene variation was associated with hyperactive
immunity and autoimmune disease.
BPI is a cationic antimicrobial protein synthesized in
the primary granules of polymorphonuclear neutrophils,
and which has broad anti-bacterial activity to all Gram-
negative bacteria.  BPI has a high affinity for endotoxin
(LPS) of Gram-negative bacteria. Binding of BPI to
bacteria is followed by envelope alteration, inhibition of
growth and irreversible loss of viability. Neutrophils
derived from newborn cord blood are deficient in BPI.
Low BPI content of newborn may contribute to the
increased risk of gram-negative infection.  Thus BPI was
studies as a candidate gene controlling immune response
to bacterial challenge.
The objectives of this study:
- Identify new polymorphisms in NRAMP1 gene
sequence and estimate the allele frequencies in local
and commercial pigs.
- Characterize the cDNA sequence, gene structure and
chromosomal location of the porcine BPI gene.
- Search for BPI polymorphisms and estimate the allele
frequencies in commercial pigs.
- Evaluate the association of NRAMP1 and BPI gene
variants and immune traits for Salmonella infection
in pigs.
Materials and Methods
Experiment I: 42 piglets (3-4 from same litter; 8-19
days old) were shipped to NADC isolation facilities.
Piglets were determined to be Salmonella-free by frequent
fecal culture.  Piglets were grown to 7-9 weeks of age
prior to intranasal challenge with 1 billion live S.
choleraesuis χ3246.  The control group (saline
inoculated) consisted of 1 piglet/litter (n = 25).  The
principal group (Salmonella infected) consisted of 2 or 3
piglets/litter (n = 59).  Animals were monitored daily for
temperature, clinical signs and Salmonella shedding
(qualitative and quantitative).  Pigs were necropsied at
post challenge day 7 and quantitative bacteriology (most
probable number) was performed on ileocecal lymph
node and from fecal samples.  Blood samples were drawn
at specific intervals during challenge and standard
complete blood counts (CBC) were performed.
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Genotyping was performed for all markers using DNA
prepared from blood. Phenotypic and genotype data were
available on 59 challenged animals from lines A and B
(15 and 44 respectively).
Experiment II: Challenged pigs were produced as part of
a reference population that was bred from sires was that
differed in susceptibility to salmonellosis. Briefly, sires
(commercial line Y) were mated to 23 F1 gilts (crosses of
commercial lines Y x Z and Z x Y).  Three to nine piglets
from each litter were selected for oral challenge with 8 x
108 S. choleraesuis (n=216). Piglets were challenged at 6
weeks of age.  Clinical signs and fever were monitored
during the six day infection period.  Blood samples were
taken from animals for immune trait measures one week
before challenge, on the day of challenge and at necropsy.
Traits of innate immunity included total leukocyte count
and differential, bacterial uptake, phagocytosis and killing
by neutrophils, and lymphocyte proliferation against
several antigens.  Six days after challenge, animals were
necropsied and the amount of Salmonella in liver and
spleen was determined by quantitative culture. Pigs were
genotyped by using marker systems described above. The
associations between sequence polymorphisms and
phenotypes for both experiments were tested using mixed
model procedures (SAS™ procedure MIXED) with a
model that always included dam as a random effect and
marker parameters as fixed effects. Least square means
were estimated for the 3 genotype classes.
Results and Discussion
Discovery of new NRAMP1 and BPI polymorphisms and
development of marker systems to detect this variation
We sequenced the beginning of the NRAMP1 gene
and identified two new polymorphisms.  One is detected
by digestion of NRAMP1 DNA with NlaIII enzyme and
the other by SmaI enzyme.  The two challenge
populations were genotyped with these new marker
systems as well as with three other published markers
(AvaII, HinfI, and MspAI1).  The polymorphisms that
segregated with the challenged animals and were thus
potentially informative for differences in disease outcome
were identified as AvaII, HinfI and NlaIII.
We cloned and sequenced the entire BPI gene and
used this new sequence information to look for
polymorphisms in the two challenge populations as done
for the NRAMP1 markers.  We identified two segregating
polymorphisms, detected with AvaII and HpaII. One of
these polymorphisms and the DNA test used to genotype
BPI for this polymorphism is shown in Figure 1.
Associations of NRAMP1 and BPI genotypes and
measures of early immune response to infection
In the following Tables, we show some of the data
indicating an association with NRAMP1 or BPI
genotypes.  Not all data is shown, only the most clear
examples of association.  For example, both AvaII and
HinfI genotypes show associations with immune traits,
but only the associations with AvaII are shown in Table 2.
Summary for NRAMP1
Multiple NRAMP1 genotypes are associated with
specific measures of innate disease resistance such as
WBC response, systemic infection and
polymorphonuclear neutrophil (PMN) function.  AvaII
allele 2 appears to be the most favorable allele. Alleles 1
and 2 are associated with a decrease in shed bacteria
(Table 1, 2) but allele 1 is associated with an increased
spleen and liver bacteria, decreased PMN function and
WBC response relative to allele 2 (Table 2).
Summary for BPI
The porcine complete protein coding sequence for the
BPI gene was successfully cloned and characterized.
Extensive polymorphism survey was identified among pig
breeds and commercial lines and porcine BPI was mapped
to chromosome 17 by both physical and linkage analysis
(data not shown).  We show that BPI AvaII is associated
with fecal shedding and immune cell response during
infection (Tabe 3) and demonstrate that co-segregating
missense mutations, A354T and R384L (detected by
HpaII digestion, not shown) are associated with altered
bacterial counts in liver and in fecal shedding post-
challenge (see Table 4).  Our finding provides the first
genetic evidence that mutations in BPI are associated with
resistance/susceptibility of Salmonella infection in pigs.
Overall, these NRAMP1 and BPI association
information may be useful for improving animal health
and performance by decreasing the extent of disease and
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Figure 1. Gel electrophoresis showing AvaII
genotyping of fragments of DNA from BPI.
The first lane is the standards for size determination.
The next three lanes show DNA from 11, 12 and 22
genotype animals.  Allele 1 is not digested while
allele 2 shows digestion to create two fragments of
417 and 123 base pairs.
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Table 1. Both AvaII and NlaIII genotypes are associated with fecal bacterial shedding (Expt. I).
AvaII                                                                                                                             
                       Allele substitution effectsa (P-value)                      
Traitb                     1-all                   2-all                   3-all               4-all
FMPND6 -.56 (.06) -.51 (.19) .14 (.73) .92 (.28)
NlaIII                                                                                                                            
                       LSmeans (s.e.)                           
Traitb                 88                  89                   99 P
FMPND6 1.19 (0.15)   2.27 (0.45)     - .0006
                                                                                                                                       
a These are log10 values; a difference of +1.0 is 10 fold higher bacterial counts. These
comparisons were performed by combining the values for animals carrying at least one copy of the
relevant allele versus animals with zero alleles. For example, for 1-all, the comparison is all
animals with genotype 11, 12, 13, etc versus animals with genotype 22, 23, 33, etc.
bFMPND6 = mean fecal Salmonella count on day 6 after challenge.
Table 2. AvaII Genotypes Associated with Internal Bacterial Counts and Immune Cell Number and
Function (Expt. II).
 Allele substitution effect*                P-values                 
Trait mean (s.e)   s.d. 1 2 3 1 vs 2   1 vs 3   2 vs 3
Spleen count 1.16 (0.09) 1.25 0.59 0.09 0 0.007 0.0012 0.56
Liver count 2.16 (0.11) 1.45 0.65 -0.02 0 0.0006 0.0006 0.91
Wbc - pre 6.63 (0.30) 3.91 -0.36 -0.23 0 0.75 0.39 0.45
Wbc – d0 7.23 (0.23) 3.01 -0.68 -0.94 0 0.49 0.08 0.009
Wbc  - d8 10.53 (0.34) 4.1 -0.54 0.87 0 0.04 0.45 0.17
Wbc - pre-d0  0.57 (0.34) 4.46 -0.08 -0.84 0 0.19 0.90 0.07
Wbc – d0-d8  3.14 (0.38) 4.58 0.02 1.67 0 0.03 0.98 0.02
Wbc - pre-d8  3.56 (0.40) 4.79 -0.52 0.86 0 0.08 0.53 0.21
PMN uptake  0.54 (0.11) 1.41 -0.07 0.29 0 0.09 0.74 0.11
PMN killing 83.48 (1.57) 20.6 -6.54 1.63 0 0.01 0.05 0.59
PMN phag  3.38 (0.56) 7.3 -0.83 0.91 0 0.03 0.32 0.18
% PMN             73.63 (1.19)   15.6    -1.99       -6.89       0             0.04          0.42          0.003  
*Allele 3 set to zero for these comparisons. These are log10 scale, so a difference of 1.0 equals a 10-fold difference in actual
value.
Trait Code             Trait description-
PMN killing Salmonella killing efficiency of Polymorphonuclear neutrophils (PMN)
Liver count Bacterial counts in liver at one week
% PMN percentage PMN's
PMN phag phagocytosis efficiency of PMN's
Spleen count Bacterial counts in spleen at one week
PMN uptake Salmonella uptake efficiency of PMN's
Wbc – pre, d0, d8 White blood cell count pre-challenge, d0 or d8 of challenge
Wbc -pre-d0 absolute value of  wbc pre –wbc d0 difference
Wbc – d0 – d8 absolute value of  wbc d 0 – wbc d8 difference
Wbc – pre – d8 absolute value of  wbc pre – wbc d8 difference
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Table 3. BPI Ava II Genotype Association with Immune Traits (Expt. I).
Trait*    LS means by Genotype (s.e.)**         
      11                 12         22 P value
tempD7 40.4 (.18) c 41.1 (.29) d - 0.08
FMPND6 0.44 (1.1) g 1.84 (1.1) h - 0.006
neut1 8.76 (.70) 8.00 (.91) - 0.42
neut2 7.56 (2.6) e 2.68 (2.8) f - 0.02
neut_diff -1.17 (2.8) g -5.35 (2.9) h - 0.008
mono1 1.17 (.29) 1.42 (.36) - 0.45
mono2 0.37 (.13) c 0.09 (.15) d - 0.05
mono_diff 1.51 (.80) e -0.34 (.89) f - 0.02
wbc1 1.31 (.04) 1.25 (.05) - 0.31
wbc2 22.7 (2.9) c 16.5 (3.4) d - 0.06
wbc_diff 2.10 (3.5) a -2.3 (4.1) b - 0.21
*Traits are: TEMPD7 = temp on day 7 of challenge; FMPND6 = mean fecal Salmonella count on day 6 after challenge; (1)
suffix means values before challenge; (2) suffix means values after challenge; _diff = difference in values before and after
challenge; wbc:white blood cell number.  Neut: neutrophil number. Mono: monocyte number.
**Significant differences (p values) for LS means are indicated as follows:
a-b: p<.30    c-d: p<.10   e-f: p<.05 g-h: p<.01   i-j: p<.005  k-l: p<.001 m-n: p<.0005 o-p: p<.0001
Table 4. BPI HpaII Genotype association with Immune Traits (Expt. II)
                                      LSmeans (s.e.)*                              
Trait        33                          34                             44          
liverC 2.24 (0.15) c  2.18 (0.23) c 3.33 (0.63) d 
lym1 56.43 (1.01) a    59.12 (1.78) b  56.29 (5.12)    
lym2 59.76 (0.96) c  58.69 (1.60) a 51.99 (4.50) d b 
lym3 46.59 (1.08)     46.46 (1.88)    -    
neu1 39.56 (1.05) a    36.81 (1.76) b   39.67 (4.95)    
neu2 36.62 (0.90) a  37.34 (1.56) a 44.00 (4.47) b 
neu3 49.10 (1.15)     48.66 (1.92)    -    
SICA_pre 210.1 (25.8) o  221.4 (43.6) o 891.8 ( 123) p     
uptake 0.34 (0.14) e    0.91 (0.24) f   0.68 (0.68)    
                                                                                                                     
*Significant differences (p values) for LS means are indicated as in Table 3.
SICA_pre: WBC Stimulation index in presence of Concavalin A pre-challenge.
